Viveve Medical (VIVE) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 12 153 sessions, November 6, 2025 to November 6, 2026
- Largest daily move
- +800% close of December 5, 2025
- 1-year change
- +100% closing prices, November 6, 2025 to November 6, 2026
- 1-month change
- +0% closing prices, October 5, 2026 to November 6, 2026
Company Description
Viveve Medical (OTC: VIVE) is classified in the medical devices industry within the Healthcare sector and carries a market capitalization of $2.1K.
VIVE has gained 100.0% over the past year. The last closing price was $0.0002.
This page collects what Stock Titan holds for VIVE, including price data, latest news, and short interest trends.
Stock Performance
Viveve Medical (VIVE) closed at $0.0002 on November 6, 2026. Over the past 12 months, the price has gained 100.0%.
VIVE Metrics & Rankings
Price returns through November 6, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
Viveve Medical has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 7 with negative movement. Key topics include clinical trial, earnings, conferences. View all VIVE news →
SEC Filings
Short Interest History
Short interest in Viveve Medical (VIVE) currently stands at 2.9 thousand shares, representing 0.0% of the float. Since November 2025, short interest has decreased by 35.6%.
Days to Cover History
Days to cover for Viveve Medical (VIVE) currently stands at 1.3 days, down 48.4% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since November 2025, the figure has increased by 30%. Across the settlements charted above, it has ranged from 1.0 to 6.9 days.
VIVE Company Profile & Sector Positioning
Viveve Medical (VIVE) operates in the Medical Devices industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing VIVE often look at related companies in the same sector, including Acutus Medical Inc (AFIB), Dynatronics Corp (DYNTQ), ThermoGenesis Holdings Inc (THMO), Motus GI Holdings Inc (MOTS), and Nemaura Medical Inc (NMRD). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate VIVE's relative position within its industry.